APSR2026-682

Yes
Late-Breaking
Submitted
Oral Presentation
AO12-006
 
 
https://storage.unitedwebnetwork.com/files/1285/1220986-46903-APSR2026-682_440014.pptx
Format: PPTX Only
 
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
3

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Anita Rahman * Universitas Indonesia Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Jakarta Indonesia
Triya Damayanthi - Universitas Indonesia Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Jakarta Indonesia
Anna Rozaliyani - Universitas Indonesia Department of Pulmonology and Respiratory Medicine, Faculty of Medicine Jakarta Indonesia
 
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Anita
Rahman
anitarahmanbaay@gmail.com
+6281917919555
31-40
Indonesia
Original Research
A Hidden Burden: Aspergillus IgG Seropositivity in Stable COPD Patients from a Tertiary Respiratory Center in Indonesia
Maximum 25 words
Abstract Content
Chronic obstructive pulmonary disease (COPD) is a recognized predisposing condition for Aspergillus-related lung disease due to structural airway damage, impaired mucociliary clearance, and frequent corticosteroid exposure. Aspergillus-specific IgG seropositivity is an established immunological marker associated with chronic pulmonary aspergillosis (CPA), reflecting sustained or recurrent fungal exposure. However, the prevalence and clinical relevance of Aspergillus IgG seropositivity among clinically stable COPD patients, particularly in tropical regions with high environmental fungal burden remain poorly defined.
A cross-sectional study was conducted among stable COPD patients attending the outpatient clinic of a national tertiary respiratory referral center in Jakarta, Indonesia. Demographic characteristics, smoking history and COPD risk classification were recorded. Serum Aspergillus-specific IgG levels were measured using standardized immunoassays.
Among 30 stable COPD patients, 16.7% demonstrated Aspergillus IgG seropositivity. Seropositive patients were predominantly male, had substantial cumulative smoking exposure, and were mostly classified within high-risk COPD groups.
Nearly one-fifth of stable COPD patients exhibited Aspergillus IgG seropositivity, indicating a clinically silent but potentially important burden of chronic fungal exposure. These findings suggest that Aspergillus-related lung involvement in COPD may exist along a continuum extending beyond overt CPA and remain unrecognized during stable disease. Further longitudinal studies are warranted to clarify the clinical implications of Aspergillus IgG seropositivity in COPD, particularly in tropical settings.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Chronic obstructive pulmonary disease, Aspergillus IgG, Fungal exposure
maximum 3 keywords and no abbreviations, separated by commas
 
210